Skip to product information
1 of 1


Using gauze on a wound, wound gauze BETAISODONA 10x10 cm

Using gauze on a wound, wound gauze BETAISODONA 10x10 cm

Regular price £46.70 GBP
Regular price £70.00 GBP Sale price £46.70 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.

Using gauze on a wound, wound gauze BETAISODONA 10x10 cm

pack size:10 pcs Dosage form:wound gauze

Betaisodona ® wound gauze 3 mg/cm 2

Active substance: povidone iodine.

Areas of Using gauze on a wound, wound gauze BETAISODONA 10x10 cm application:


Betaisodona ® wound gauze is a germicidal agent (antiseptic) for use on skin and wounds. Betaisodona ® wound gauze is used as a germicidal bandage to prevent skin infections where there is a high probability of infection, to treat skin infections, to treat cuts and abrasions and other injuries to prevent infection, to treat burns of the skin, bed sores, pressure sores and infected leg ulcers (decubitus, Leg Ulcer).

Keep medicines out of the reach of children.

For risks and side effects, read the leaflet and ask your doctor or pharmacist.
Status: 07/20

To prevent skin infections.

active Using gauze on a wound, wound gauze BETAISODONA 10x10 cm ingredients

  • 300 mg povidone iod

Using gauze on a wound, wound gauze BETAISODONA 10x10 cm excipients

  • Macrogol 400
  • Macrogol 4000
  • Macrogol 6000
  • water, purified
  • cotton (gauze)

Using gauze on a wound, wound gauze BETAISODONA 10x10 cm indication

  • The preparation is a germicidal agent (antiseptic) for use on skin and wounds.
  • The medicinal product is used as a germicidal dressing for:
    • Prevention of skin infections when there is a high probability of infection,
    • treatment of skin infections,
    • anti-infective treatment of cuts, abrasions and other injuries,
    • anti-infection treatment for skin burns, bed sores, pressure sores and infected lower leg ulcers (decubitus, leg ulcers).

dosage Using gauze on a wound, wound gauze BETAISODONA 10x10 cm

  • Always use the medicine exactly as directed. Please check with your doctor or pharmacist if you are not sure.
  • Unless otherwise prescribed by the doctor, the preparation is usually used as follows.
    • The drug is applied at each dressing change. In the initial phase or in the case of heavily infected wounds, the wound gauze can also be changed several times a day.
  • The brown coloring of the ointment contained in the drug is a property of the preparation and indicates its effectiveness. Increasing discoloration indicates a decrease in the effectiveness of the preparation. If the color is completely removed, it is no longer effective. If you notice an extensive discoloration of the ointment, you should put on a new gauze.


  • duration of use
    • The use of the drug should be continued as long as signs of inflammation persist. If your symptoms have not improved after several days (2 to 5 days) of regular use of the preparation, or if symptoms recur after the end of treatment, please consult your doctor.


  • If you use more than you should
    • see category "side effects"

Using gauze on a wound, wound gauze BETAISODONA 10x10 cm way

  • Tear open the pouch as shown and remove the gauze. Remove the protective film and place the wound gauze on the diseased or injured area of ​​skin. You can put on a bandage over the wound gauze.

side effects

  • Like all medicines, the preparation can have side effects, although not everyone gets them.
  • The evaluation of side effects is based on the following frequency information:
    • Very common: more than 1 in 10 people treated
    • Common: less than 1 in 10 but more than 1 in 100 people treated
    • Uncommon: less than 1 in 100 but more than 1 in 1,000 people treated
    • Rare: less than 1 in 1,000 but more than 1 in 10,000 people treated
    • Very rare: less than 1 in 10,000 people treated, or unknown
  • possible side effects
    • Immune system disorders/skin disorders
      • Rarely
        • Hypersensitivity reactions of the skin, eg delayed-type contact allergic reactions, which can manifest themselves in the form of itching, reddening, blisters, burning sensations or similar.
      • Very rare
        • Acute general allergic reactions, possibly with drop in blood pressure and/or shortness of breath (anaphylactic reactions); Acute swelling of the skin or mucous membranes (angioedema or Quincke's edema).
    • endocrine diseases
      • Significant iodine uptake can occur with long-term use of the preparation on extensive areas of skin, wounds or burns.
      • Very rare
        • Hyperthyroidism (iodine-induced hyperthyroidism), possibly with symptoms such as increased pulse rate or inner restlessness in patients with thyroid disorders.
    • Metabolic and nutritional disorders/diseases of the kidneys and urinary tract
      • Rarely
        • After the use of large amounts of medicines containing povidone-iodine (e.g. in the treatment of burns): Electrolyte and serum osmolarity disorders, impairment of kidney function, acidification of the blood (metabolic acidosis).
  • If you get any side effects, talk to your doctor or pharmacist. This also applies to side effects that are not specified.

Using gauze on a wound, wound gauze BETAISODONA 10x10 cm interactions

  • When using the preparation with other medicines
    • Please inform your doctor or pharmacist if you are taking/using or have recently taken/used other medicines, even if they are non-prescription medicines.
    • Povidone-iodine can react with protein and various other organic substances such as blood and pus components, which can reduce its effectiveness.
    • With the simultaneous use of the preparation and enzymatic wound treatment agents, the enzyme component is oxidized by iodine, thereby weakening the effect of both drugs.
    • A mutual weakening of the effect also occurs when the drug is used simultaneously with hydrogen peroxide, taurolidine and silver-containing disinfectants or silver-containing wound dressings (formation of silver iodide).
    • The preparation must not be used at the same time or for a short time afterwards with mercury-containing disinfectants, since under certain circumstances a substance can form from iodine and mercury that damages the skin.
    • Do not use the drug at the same time as or immediately after using disinfectants containing the active ingredient octenidine on the same or adjacent areas, as this may result in temporary dark discoloration.
    • If you are treated with lithium preparations, you should avoid long-term and/or extensive use of the preparation, as absorbed iodine can promote the possible lithium-induced hypothyroidism.
    • For information on the discoloration of materials, see the "Patient information" category.
    • Influencing diagnostic tests or radioiodine therapy
      • Because of the oxidizing effect of the active ingredient povidone-iodine, various diagnostics can deliver false-positive results during treatment with the drug (including toluidine and guaiac resin for determining hemoglobin or glucose in the stool or urine).
      • The uptake of iodine by the thyroid gland can be influenced by povidone-iodine; this can lead to disruptions in diagnostic examinations of the thyroid gland (thyroid scintigraphy, PBI determination, radioiodine diagnostics) during treatment with the preparation and make a planned radioiodine therapy impossible. There should be an interval of at least 1-2 weeks after stopping treatment with the drug before recording a new scintigram.
  • When using the drug with food and drink
    • Not applicable.


  • The medicine must not be used:
    • if you have an overactive thyroid gland (hyperthyroidism) or another existing (manifest) thyroid disease,
    • in the very rare chronic skin inflammation dermatitis herpetiformis Duhring,
    • during and until the end of radiation therapy with iodine (radio-iodine therapy) or if you are planning such a treatment,
    • if you are hypersensitive (allergic) to the active substance or any of the other ingredients of the preparation.

pregnancy and breast feeding period

  • Ask your doctor or pharmacist for advice before using any medicine.
  • During pregnancy and lactation, the drug is to be used only on the express instructions of the doctor and is extremely limited. In this case, it is necessary to check the thyroid function in the child.
  • Ingestion of the ointment contained in the preparation by the infant through the mouth through contact with the treated part of the nursing mother's body must be avoided.

patient notes

  • Special care is required when using the drug
    • If you suffer from thyroid disease or you have a goiter, you should only use the medicine over a long period of time and over a large area (eg over 10% of the body surface and longer than 14 days) if your doctor has expressly instructed you to do so.
    • Even after the end of the therapy (up to 3 months) one should pay attention to early symptoms of a possible hyperthyroidism and, if necessary, monitor the thyroid function.
    • Elderly people
      • Since older people are more likely to suffer from thyroid dysfunction, older people (>/= 65 years) should only use the drug over a large area and over a longer period of time if expressly instructed by their doctor. If necessary, monitor thyroid function.
    • newborns and infants
      • In newborns and infants up to the age of 6 months, the preparation is to be used only on the express instructions of the doctor and in an extremely limited manner. A check of the thyroid function is necessary.
      • Ingestion of the ointment contained in the preparation by the infant when breastfeeding must be avoided.
    • a notice
      • The ointment contained in the gauze is fat-free and washable. In general, it can be removed from textiles and other materials with warm water and soap. In stubborn cases, ammonia (ammonia solution) or fixing salt (sodium thiosulphate) will help. Both are available in pharmacies or drugstores.


  • Driving and using machines
    • The preparation has no influence on the ability to drive and use machines.


Shipping & Returns


Care Instructions

View full details